Allergan begins trials on hair-growth drug
Drugmaker Allergan is recruiting volunteers for clinical trials of a hair-growth treatment based on the active ingredient in Latisse (bimatoprost ophthalmic solution, 0.03 percent), the company’s eyelash-growth treatment. (Source: Modern Medicine)
Read more here:
Allergan begins trials on hair-growth drug
AAD: Glaucoma Drug Boosts Eyelash Growth
SAN FRANCISCO (MedPage Today) — Patients with skimpy eyelashes experienced significant growth and thickening when they applied bimatoprost (Latisse), an ophthalmic solution normally used to treat glaucoma, according to a randomized clinical trial reported here. (Source: MedPage Today Dermatology) MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network , and receive $5 free advertising.
More here:
AAD: Glaucoma Drug Boosts Eyelash Growth
Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse — First and Only Treatment Approved by the FDA for Hypotrichosis of…
IRVINE, Calif.–(BUSINESS WIRE)–Dec 26, 2008 – Allergan, Inc.
Read the original:
Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse — First and Only Treatment Approved by the FDA for Hypotrichosis of…
Epione Beverly Hills- Treatment For Sun Damaged Skin
- Breast Plastic Surgery – Symmetry, Form and Beauty
- Facial Acne Scars: Erasing The Marks Of Your Youth
- Danielle Staub from the Real Housewives of New Jersey receives Botox treatment at Epione Beverly Hills
- Do You Hate Your Acne Scars?
- The return of perfect skin
- Would You Like To Get Fuller Lips?
- Facial Wrinkle Removal: Getting Rid Of Facial Wrinkles
- Acne Scars: Information About Reducing The Appearance Of Acne Scars
- Cellulite Removal: Know The Facts